THE
FUTURE
OF CANNABIS SCIENCE
Know exactly what your cannabis products do. Canalytics turns the COA you already have into a scored effect profile, 30 therapeutic and adult use effects on a 0 to 10 scale, supported by 10,000+ peer-reviewed studies. Eight integrated platforms carry that science from seed to shelf to clinic, so every decision in the industry runs on chemistry instead of strain names.
Cannabis Science,
Made Measurable
Canalytics is built on proprietary algorithmic and machine learning analysis rather than an AI black box. Where an AI model cannot fully show or reproduce the neural network processes behind its responses, every Canalytics effect score, match and recommendation follows an explicit calculation from input chemistry to output, traceable to its inputs and identically reproducible on every run. That scientific foundation drives decision making across every sector of the cannabis industry, matching products to effects, moods, activities and clinical recommendations with evidence that can be inspected and defended.
Solutions for
Canalytics turns decades of research into software platforms built for each sector of the industry, so anyone, whatever their cannabis knowledge, can make science-backed decisions.
Brands
Know what your products do before you make them. Score every SKU by effect, find the gaps and overlaps in your line, prove your marketing claims with the chemistry in the jar, and match every customer to the right product on your own store. Brands that can show the evidence stop competing on buzzwords.
Dispensaries
Match every customer to the product that will actually deliver, online and at the counter. Effect-based shopping that filters out what they want to avoid, a 24/7 chat assistant trained on thousands of studies, procurement screened against your current inventory and demand audit. The right first purchase is what brings them back.
Cultivators
Decide what to grow with evidence instead of trends. Score your entire clone and seed library, pre-qualify seed lines before a full phenohunt, turn every harvest COA into a documented chemistry asset, and sell B2B on effect coverage rather than price per pound.
Processors & Manufacturers
Formulate against outcomes instead of available biomass. Score every input you hold or could source and find the combinations that rate highest for each product line's target effects, moods, medical uses and use cases, across your whole catalog at once.
Clinicians & Clinics
Recommend with evidence, not intuition. A patient intake produces a study-backed, personalized cannabis recommendation: every in-stock product scored per condition, drug interactions and contraindications flagged, and dosing guidance included, all determined by a robust study database. HIPAA-grade, and works with or without an EMR.
Breeders & Phenohunters
Simulate every parent cross at every ratio in 30 seconds, then rank real phenotypes by any single or combined effects, mood, activity or target audience. Breed toward documented demand and build a genetics library with scientific decision making that compounds every cycle.
Research & Universities
Work from a ready analytical foundation instead of assembling one from primary literature. Every chemovar receives a scored percentage showing how closely it aligns with your research criteria, drawn from 10,000+ studies, alongside receptor-level pharmacology, a cancer chemovar alignment framework, breeding simulation and a clinical recommendation layer. Deterministic, reproducible, ready on day one.
Testing Labs
Turn the COA you already produce into the most valuable document in your client's business. White-label Canalytics intelligence under your own brand, grow testing relationships into recurring intelligence services, and become the chemistry intelligence layer for your region.
Pharmaceutical
Deploy pharmaceutical-depth cannabis analytics on day one instead of building them over years. Specify target medical effects and score chemovars by match %, screen the plant universe for natural optimal formula matches and direct seed hunting and breeding toward it. Run multi-pathway cancer chemovar alignment and standardize clinical trial decision support across sites.
Eight Platforms. One Scientific Engine.
Every Canalytics webapp draws on the same proprietary scoring engine, which means data flows between them without friction. A phenotype scored in Breeding becomes a procurement candidate in Audit, a recommended product in Shop, and a clinical recommendation for a specific patient in the Cannabis Clinical Suite. Deploy one platform or the full suite.
Canalytics Shop
Every in-stock product gets a personalized match score and the catalog re-sorts as the customer's needs change. Counter-effect filtering (Calm without Couchlock), a natural-language product finder, a 24/7 AI Chat Assistant trained on Canalytics' proprietary research of over 10,000 studies, time-of-day smart cart, demand intelligence and Shopify integration.
Canalytics Business
Automatic COA sync via Dutchie and POS API integrations, plus upload and photo capture from any lab — effect scoring, multi-tab strain comparison, effect-based search, buyer personas, infusion pairings and a complete B2B procurement system with Field Mode for trade-show buying and Remote Analysis Mode for evaluating supplier COAs.
Cannabis Clinical Suite
A proprietary algorithmic matching engine, not a medical treatment. From a structured patient intake it ranks every available product by how closely its cannabinoid and terpene profile aligns with what 10,000+ peer-reviewed studies associate with the patient's stated needs, in under 60 seconds. Drug interaction and contraindication flags, dosing guidance and a traceable rationale. HIPAA-grade and EMR-independent.
Canalytics Breeding
Simulates every possible parent cross at every plausible genetic contribution ratio and ranks the predicted offspring by effect profile in about 30 seconds. Multi-effect optimization, parent analysis with optimal ratio detection, phenohunt ranking and a full breeding strategy report.
Canalytics Plant Match
Searches any genetic library for the chemovar whose cannabinoid and terpene ratios most closely match a target profile — whether that target is a best-seller, a competitor sample, a pharmaceutical specification, or a designer profile reverse-engineered from clinical research and licensed from Canalytics. Weighted similarity scoring with a full per-compound breakdown.
Canalytics Cancer Chemovar Alignment
Evaluates cannabis chemovars across multiple weighted pathways and cancer types — identifying which cannabinoid and terpene profiles clinical research most consistently associates with each cancer category. Documented synergy modeling, ML clustering, dimensionality reduction and feature importance analysis. Built for cancer support clinics, palliative networks, research programs and pharmaceutical development.
Canalytics Promote
Scores every piece of marketing content across multiple dimensions against chemistry-validated buyer personas, reads its emotional fingerprint, rewrites for tone and persuasion, and builds full multi-platform campaigns in minutes. Every claim anchored to the actual chemistry of the product being sold.
Canalytics Audit
Turns a catalog of SKUs into a scored, analyzable asset. An automated, multi-chapter audit covering inventory strength, effect coverage, quality, optimization, customer targeting, competitive analysis and forward recommendations, plus gap analysis, price elasticity, revenue simulation and multi-location comparison.
Scored on What It Actually Does
Every product Canalytics analyzes is scored across 30 therapeutic and adult use effects on a 0 to 10 scale, from the full cannabinoid and terpene fingerprint in its COA. This is the shared vocabulary that lets a breeder target an effect, a dispensary sort a shelf by it, a marketer write to it, and a clinician recommend against it.
Therapeutic Effects Analyzed
Condition-relevant effects scored from receptor-level pharmacology, so clinical positioning and evidence-aligned recommendations rest on science.
Adult Use Effects Analyzed
Experience-relevant effects that predict how a product actually feels, so customers can shop by outcome instead of by strain name and THC percentage.
Plus 17 Additional Effects
Beyond the effects shown above, Canalytics scores 17 additional therapeutic and adult use effects on every product, delivering the most complete effect profile in the industry and the depth needed to filter for what a customer wants and against what they want to avoid.
0 to 10 Scale
Every effect is quantified, not described. Products become sortable, comparable and rankable against any target.
Counter-Effect Filtering
Find high Calm and low Couchlock, or Focus without Anxiety. Score for the effects wanted and against the effects to avoid.
Receptor-Level Mapping
Cannabinoids and terpenes mapped to CB1, CB2, TRPV1, 5-HT1A, PPARγ, opioid μ and more, so scores rest on mechanism.
Robust Study Database
Every score is supported by a robust study database of peer-reviewed research. No black box.
One Prediction Engine, Every Stage of the Cannabis Supply Chain
Canalytics gives the entire cannabis ecosystem a shared language: effect prediction that changes how decisions get made at every step. Breeders simulate crosses before a seed is germinated. Cultivators grow what documented demand actually wants, not what sold last year. Processors formulate to a target chemovar and validate every batch against it. Testing labs evolve from commodity testing fees into recurring intelligence services. Dispensaries and brands match every customer to a product that delivers, then stock and market from evidence instead of instinct. Clinicians recommend with per condition scoring and drug interaction screening built in.
Every Interaction Makes the Whole System Smarter
Canalytics is not just a collection of tools, it provides a closed loop. What customers actually seek flows upstream into what gets bred and grown. What gets bred and grown flows into what gets formulated and stocked. What gets stocked flows into what gets matched to each customer and patient. Then the outcomes flow back to the start, sharpening every prediction that comes after.
Consumer Demand Signals
Effect-based browsing, AI Chat Assistant consultations, persona clustering and purchase likelihood reveal what customers and patients actually seek.
Genetic Selection
Breeders and cultivators choose what to develop with demand evidence fed into Breeding simulations and Plant Match target profiles.
Product Creation
Brands and processors formulate and stock to documented demand using Audit intelligence and Business procurement.
Personalized Matching
Shop, Promote and the Cannabis Clinical Suite match every product to every need, and the outcomes feed back into stage one.
Designer Cannabis Formulas
100+ Scientifically Engineered Effect Profiles. License, Partner, or Purchase.
Canalytics has reverse-engineered 100+ precision cannabinoid and terpene formulas from 10,213+ studies, each targeting a specific therapeutic or adult use effect profile. Instead of hoping a product hits a need, you start from a documented target and build toward it. Formulate concentrates, edibles, tinctures, vapes or topicals to the profile, or find and breed flower genetics that match it with Plant Match and Breeding. Every formula is defined by chemistry, scored across all effects and supported by a robust study database.
License
License a formula for a product line, a format or a market and launch with a documented effect profile from day one.
Partner
Co-develop with the Canalytics scientific team, from target specification through genetic sourcing, formulation and batch validation.
Purchase
Acquire a formula outright for exclusive use in your category or region and own a defensible chemistry asset.
Evening Calm, Daytime Clear
Persona: Calm-Seeking Professional
Illustrative values shown. Actual formulas are defined by full cannabinoid and terpene specifications.
Instant scientific understanding and analysis
For pharmaceutical partners developing cannabis-derived therapeutics against specific clinical indications, Canalytics offers an exclusive engagement tier: target chemovar specification at pharmaceutical depth, multi-pathway cancer chemovar alignment analytics, breeding direction support, IND-supporting documentation and direct partnership with our scientific team.
The People Behind the Engine
Canalytics was built by people who have spent their careers on opposite ends of the same problem. On one side, two decades of research into the endocannabinoid system and the ways cannabinoids and terpenes work together, distilled into the scoring engine every Canalytics platform runs on. On the other, 23 years building labs, cultivation facilities, dispensaries and brands, learning firsthand what the industry needs and where it guesses. Between them sits a scientific advisory board of board-certified physicians practicing cannabinoid medicine, who make sure every score, recommendation and formula stands up to clinical scrutiny. Research that has to survive in the real world, and operators who insist on evidence.
Matthew Widmer
Matthew brings over two decades of extensive research and technological innovation to Canalytics. His multidisciplinary background in neuroscience, cognitive science, and computer science, and comprehensive analysis of 10,000+ studies on the endocannabinoid system and cannabinoid-terpene effect synergy provide a robust scientific foundation for Canalytics' cutting-edge algorithmic analysis systems. Matthew brings an impressive track record in designing sophisticated computational systems. In 2007, he spearheaded the development of a Crestron automation system with 5,000+ relays. Throughout his career, Matthew has been at the forefront of advancements ranging from digital therapeutics and VR/AR to innovative health-boosting systems utilizing emotion tracking feedback loops for personalized recommendations.
Brent Stevens
Brent Stevens, co-founder of Flower Mill and Canalytics, brings 23 years of expertise in the cannabis industry, spanning innovative product development, building labs, cultivation facilities, dispensaries, managing medical grows and founding multiple global brands. Including founding, patenting and spearheading the award-winning Flower Mill company, now a staple in the industry. With a background in c-suite company development and sales, Brent also founded The Shire Group, streamlining operations and compliance for businesses. Committed to social responsibility, he supports initiatives providing cannabis to communities in need. Brent's laser focus on improving cannabis quality and experience across therapeutic and adult use cannabis has driven advancements shaping the industry.
Dr. Janice Knox, MD, MBA
Dr. Janice Vaughn-Knox, MD, MBA is a retired board certified anesthesiologist, endocannabinologist, and certified cannabinoid medicine specialist. Dr. Janice is one of a family of 4 clinicians that believes science, research and technology will disrupt health care as it has been known. The future of cannabis medicine will depend on how well the physiology of the body is known and the correct clinical application of the pharmacology of cannabis and other botanicals.
Dr. Jessica Knox, MD, MBA, MPH
Dr. Jessica Knox is a board-certified preventive medicine physician with 6 years of clinical experience in cannabinoid medicine. Dr. Jessica is a co-founder of several organizations, including co-founder of Doctors Knox, Inc. and Pivital Holdings; and the Association for Cannabis Health Equity and Medicine (ACHEM), the first national medical association for BIPOC professionals seeking to heal themselves and their communities through cannabis education, advocacy, and application.
Dr. Rachel Knox, MD, MBA
Dr. Rachel Knox, MD, MBA is an endocannabinologist specializing in cannabinoid medicine, and a policy expert on cannabis and psychedelic health equity. She's the creator and president of the Cannabis Health Equity Movement (CHEM)®, comprising the Association for Cannabis Health Equity and Medicine (ACHEM), CHEM Allyance, and CHEM Cooperative; and is co-founder of Doctors Knox, Inc. and Pivital Holdings. She is the immediate past chair of the Oregon Cannabis Commission, immediate past Vice Chair and Equity Chair of the Oregon Psilocybin Advisory Board, and a founding board member of Cannabis Regulators of Color Coalition (CRCC).
Dr. David Knox, MD
Dr. David Knox is a board certified emergency medicine physician with nearly a decade of clinical experience in cannabinoid medicine. Along with his family, Dr. David founded Doctors Knox, Inc., the American Cannabinoid Clinics, delivering precision cannabinoid medicine to patients; and Pivital Edu, which develops comprehensive training for healthcare professionals in the ECS, endocannabinology and cannabinology.
Doctor Testimonials
"Canalytics is the realization of my vision for the cannabis industry, which is why I am thrilled to join the company's Scientific Advisory Board. Canalytics is pioneering the integration of science, physiology, and technology to deliver data-backed solutions targeting medical conditions, exactly what I've been eagerly anticipating for the past decade. Their technology eliminates guesswork for the entire supply chain by illuminating the intricacies of cannabis' effects."
"As an endocannabinologist, I'm excited to contribute expertise to Canalytics' Scientific Advisory Board, driving innovation and impact. Canalytics adeptly combines scientific rigor with innovation illuminating cannabis' complexities through proprietary tech. This enables unprecedented customization - from breeding, product develop, product recommendations to novel formulations and increased efficacy in cannabis medicine."
"Cannabis is a polypharmacy with multiple cannabinoids, terpenes, and phytochemicals. Precision in clinical use has been an issue, addressed through trial-and-error to find optimal results per patient. Canalytics' integration of science and technology offers great potential for a better approach to personalized botanical medicine."
"Canalytics delivers a groundbreaking solution that clinical endocannabinologists have long awaited - sophisticated tech offering novel insights into diverse phytochemicals and their impact on human physiology. This unlocks the potential of personalized botanical medicine and self-care at an unprecedented scale. I am honored to help guide the development and deployment of this revolutionary technology."
Cannabis Effect Science, Built From Evidence
Canalytics is built on 20+ years of proprietary cannabinoid and terpene research and a continuously expanding knowledge base of 10,213+ peer-reviewed studies, powering a suite of software that puts that science to work across every sector of the cannabis industry. That distinction matters. The core of Canalytics is not a chatbot dressed as a platform or a black-box model that guesses. Every effect score, match percentage, breeding prediction and clinical recommendation comes from proprietary algorithms that translate input chemistry into output results. Canalytics understands what you ask in plain language, whether you are a patient describing symptoms, a customer describing the effects they want, or a dispensary buyer deciding what to stock, and routes that request into the system.
Deterministic Engine, Not a Black Box
Hard-coded scoring algorithms encoding documented pharmacological logic. Every step of every analysis can be inspected, reproduced and explained.
Full Traceability
Ask why a product scores the way it does and get the compounds and receptor mechanisms behind the answer, backed by our proprietary study database.
Receptor-Level Pharmacology
Cannabinoids and terpenes mapped to CB1, CB2, TRPV1, TRPA1, TRPM8, 5-HT1A, D2, GPR55, PPARγ and opioid μ, the language clinicians and pharma use natively.
Closed-Loop Learning
Customer outcomes, clinical assessments and purchase behavior continuously refine the data the engine draws on, while the logic stays transparent and auditable.
Let's Show You What's Possible
Ready for live demonstration? We will walk through your specific use case, whether you are a single-location dispensary, a national brand, a breeding program, a testing lab, a clinical practice or a research institution, and show you exactly what Canalytics would change in your operation.
Platform Demo
A live walkthrough, tailored to your industry, your use case and your operational context.
SaaS Service Options
Discuss subscription options for Canalytics' services — deployed against your real COAs, real inventory, real customers or real clinical workflows, with the flexibility to scale across platforms as your needs grow.
Pharma-Grade Tier
Designer Cannabis Formulas engagement for pharmaceutical partners, brands and manufacturers who require pharmaceutical-depth chemovar specification and multi-pathway analytics.